Angle PLC Announces HER2 Presentation at SABCS
ANGLE Presents Two Posters at EACR
Angle PLC Announces Agreement With Recursion Pharmaceuticals
Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
Angle PLC Announces Parsortix and Assays Being Showcased at EACR 2024
ANGLE Full Year 2023 Earnings: EPS Misses Expectations
ARTIFICIAL INTELLIGENCE IN THE SPOTLIGHT AS T. ROWE PRICE DEBUTS SEASON TWO OF "THE ANGLE" PODCAST
Angle Plc to Raise GBP10.6 Million via Share Placing, Subscription, Open Offer
ANGLE Unveils £10.5m Fundraise to Support Growth | AIM:AGL, OTCQX:ANPCY
U-blox Launches Comprehensive Bluetooth Angle-of-Arrival Solution to Enable Reliable Indoor Asset Tracking
Wilmington Eye Now Offering IDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma
ANGLE's Parsortix System Aids in Cancer Trial Predictions
Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix
Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca
ANGLE Inks Supplier Agreement With AstraZeneca To Develop A Parsortix-Based Androgen Receptor Detection Assay For Use In Prostate Cancer Studies
ANGLE Plc Strikes Deal on Cancer Assay Development
ANGLE Partners With AstraZeneca in Groundbreaking Oncology Contract
Angle Plc to Develop New Cancer Assay in Deal With AstraZeneca
Global Autocollimators Strategic Industry Report 2023-2030: Increasing Significance of Precise Angle Measurements in Industries Propels Demand
Liquid Biopsy Firm Angle Signs New Commercial Agreement With AstraZeneca
Unlock the Full List